Tarka (AbbVie Inc.)
Welcome to the PulseAid listing for the Tarka drug offered from AbbVie Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AbbVie Inc. |
| NON-PROPRIETARY NAME: | Trandolapril and Verapamil Hydrochloride |
| SUBSTANCE NAME: | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1996-10-22 |
| END MARKETING DATE: | 0000-00-00 |
Tarka HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tarka from AbbVie Inc. |
| LABELER NAME: | AbbVie Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2; 180(mg/1; mg/1) |
| START MARKETING DATE: | 1996-10-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0074-3287_95783c64-ca5e-5b93-18c9-e1cae9997778 |
| PRODUCT NDC: | 0074-3287 |
| APPLICATION NUMBER: | NDA020591 |
Other TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
